A study on the feasibility of the clinical sequence in pediatric hematological malignancies
Not Applicable
- Conditions
- Hematological malignancy
- Registration Number
- JPRN-UMIN000034243
- Lead Sponsor
- Japan Children's Cancer Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
/Cases judged inappropriate for this study by the principal investigator or sub-investigators /Cases scheduled to participate in other studies for treatment purposes (sponsor-initiated clinical trials, investigator-initiated clinical trials, interventional clinical trials)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of cases in which PAF was identified by introducing the clinical sequence.
- Secondary Outcome Measures
Name Time Method /Proportion of identification of CIF /An average number of days to return analysis results to the attending doctor /Proportion of cases unable to analyze genome and the cause /Proportion of cases in which germline mutation to be returned was identified